AxoGen, Inc. Makes First Sale to Rizzoli Orthopaedic Institute in Italy

Italy’s largest tissue bank and medical distributor, Rizzoli Orthopaedic Institute, will receive its first shipment of AxoGen, Inc.’s, Avance(R) Nerve Graft, which bridges the gap between severed nerves in patients.

“Our ongoing partnership with the prestigious Rizzoli Orthopaedic Institute underscores the quality of AxoGen’s tissue processing and confirms the growing demand for Avance(R) Nerve Graft in markets outside of the United States,” says Karen Zaderej, AxoGen’s chief executive officer, in a press release.

 

Related posts